SCHEMBL14045334

SCHEMBL14045334

COc1ccc(S(=O)(=O)CF)cc1NC(=O)Nc1ccc(C)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.53
ALDH1A1 P00352 8/20 0.49
POLB P06746 1/20 0.49
KMT2A Q03164 9/20 0.49
MEN1 O00255 7/20 0.49
RAB9A P51151 2/20 0.48
TP53 P04637 4/20 0.48
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
GAA P10253 1/20 0.48
MAPK1 P28482 1/20 0.48
LMNA P02545 3/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HTT P42858 2/20 0.47
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14045338 0.86 MAPT (0.64) MAPTALDH1A1POLBKMT2AMEN1
SCHEMBL4241701 0.84 MAPT (0.51) MAPTALDH1A1POLBKMT2AMEN1
SCHEMBL4238303 0.77 MAPT (0.53) MAPTALDH1A1POLBKMT2AMEN1
SCHEMBL16441098 0.74 KMT2A (0.71) MAPTALDH1A1KMT2AMEN1RAB9A
SCHEMBL11242760 0.74 ALDH1A1 (0.52) MAPTALDH1A1POLBKMT2AMEN1
SCHEMBL4242584 0.70 MAPT (0.61) MAPTALDH1A1KMT2AMEN1RAB9A
SCHEMBL4240767 0.70 MAPT (0.61) MAPTALDH1A1KMT2AMEN1RAB9A
SCHEMBL18377753 0.70 CA2 (0.76) MAPTKMT2AMEN1CA12CA1
SCHEMBL13556582 0.70 TP53 (0.61) MAPTALDH1A1POLBKMT2AMEN1
SCHEMBL4387886 0.70 MAPT (0.57) MAPTALDH1A1KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas MILLER SCOTT 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas BRAF, RAF1, MAP2K2 MAPT 1525/4885ALDH1A1 2032/4885POLB 2606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.